The Cell and Gene Therapy Roundtable Discussions Strategy Meeting is free to attend for qualified end-users.These include Senior Executives of Cell and Gene Therapy (from medium to large Pharma, Biopharma and Biotech players) as well as thought leaders from Academia and regulatory authorities
Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Cell and Gene Therapy.
The Cell and Gene Therapy Roundtable Discussions Strategy Meeting is free to attend for qualified end-users.These include Senior Executives of Cell and Gene Therapy (from medium to large Pharma, Biopharma and Biotech players) as well as thought leaders from Academia and regulatory authorities
Thought leaders who will benefit from attending include Chief Executive Officer, Chief Scientific Officer, SVPs, EVPs, VPs, Executive Director, Director and Global Head responsible for:
– Cell Therapy, Cell Engineering, Biotherapeutics, Regenerative Medicine, Immune Deficiencies, CAR-T, Cellular Immunotherapy, Supply Chain, and Manufacturing.
Register now and Book your seat. Limited slots only.
Sign up and follow your favorite conferences.